Cargando…

DFT and MD simulation investigation of favipiravir as an emerging antiviral option against viral protease (3CL(pro)) of SARS-CoV-2

As per date, around 20 million COVID-19 cases reported from across the globe due to a tiny 125 nm sized virus: SARS-CoV-2 which has created a pandemic and left an unforgettable impact on our world. Besides vaccine, medical community is in a race to identify an effective drug, which can fight against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Pooja, Rana, Meenakshi, Chowdhury, Papia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342190/ https://www.ncbi.nlm.nih.gov/pubmed/34376872 http://dx.doi.org/10.1016/j.molstruc.2021.131253

Ejemplares similares

Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations
por: Lakhera, Shradha, et al.
Publicado: (2022)

Favipiravir: A new and emerging antiviral option in COVID-19
por: Agrawal, Umang, et al.
Publicado: (2020)

Novel Polymorph of Favipiravir—An Antiviral Medication
por: Goloveshkin, Alexander S., et al.
Publicado: (2021)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

Effectivity of repurposed drugs against SARS-CoV-2 infections, A hope for COVID 19: inhibitor modelling studies by docking and molecular dynamics
por: Yadav, Pooja, et al.
Publicado: (2022)

Future of antivirals in COVID-19: The case of favipiravir
por: Kow, Chia Siang, et al.
Publicado: (2022)

Viral 3CL(pro) as a Target for Antiviral Intervention Using Milk-Derived Bioactive Peptides
por: Behzadipour, Yasaman, et al.
Publicado: (2021)

Structural similarities between SARS-CoV2 3CL(pro) and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals
por: Bafna, Khushboo, et al.
Publicado: (2022)

Favipiravir – a Modern Antiviral Drug: Synthesis and Modifications
por: Titova, Yulia A., et al.
Publicado: (2020)

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
por: Mayor, Jennifer, et al.
Publicado: (2021)

PAMAM and polyester dendrimers as favipiravir nanocarriers: a comparative study using DFT method
por: Bazyari-Delavar, Sekineh, et al.
Publicado: (2021)

Self-Assembly of Diamondoid Molecules and Derivatives (MD Simulations and DFT Calculations)
por: Xue, Yong, et al.
Publicado: (2010)

Effects of the RNA-Polymerase Inhibitors Remdesivir and Favipiravir on the Structure of Lipid Bilayers—An MD Study
por: Bringas, Mauro, et al.
Publicado: (2022)

Favipiravir elicits antiviral mutagenesis during virus replication in vivo
por: Arias, Armando, et al.
Publicado: (2014)

Potential and action mechanism of favipiravir as an antiviral against Junin virus
por: Zadeh, Vahid Rajabali, et al.
Publicado: (2022)

Favipiravir and Its Structural Analogs: Antiviral Activity and Synthesis Methods
por: Konstantinova, I. D., et al.
Publicado: (2022)

Adsorption of Favipiravir on pristine graphene nanosheets as a drug delivery system: a DFT study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023)

Understanding structural and molecular properties of complexes of nucleobases and Au13 golden nanocluster by DFT calculations and DFT-MD simulation
por: Hashemkhani Shahnazari, Ghazaleh, et al.
Publicado: (2021)

Probing calcium solvation by XAS, MD and DFT calculations
por: Yang, Feipeng, et al.
Publicado: (2020)

Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
por: Shiraki, Kimiyasu, et al.
Publicado: (2022)

Antiviral efficacy of favipiravir against canine distemper virus infection in vitro
por: Xue, Xianghong, et al.
Publicado: (2019)

Voltammetric sensor based on bimetallic nanocomposite for determination of favipiravir as an antiviral drug
por: Mehmandoust, Mohammad, et al.
Publicado: (2021)

QM/QM studies for Michael reaction in coronavirus main protease (3CL(Pro))
por: Taranto, Alex G., et al.
Publicado: (2008)

In silico identification and molecular dynamic simulations of derivatives of 6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide against main protease 3CL(pro) of SARS-CoV-2 viral infection
por: Sinha, Prashasti, et al.
Publicado: (2023)

Experimental spectra, electronic properties (liquid and gaseous phases) and activity against SARS-CoV-2 main protease of Fluphenazine dihydrochloride: DFT and MD simulations
por: Al-Otaibi, Jamelah S., et al.
Publicado: (2022)

An Antiviral Mechanism of Nitric Oxide: Inhibition of a Viral Protease
por: Saura, Marta, et al.
Publicado: (1999)

A dispersion-corrected DFT calculation on encapsulation of favipiravir drug used as antiviral against COVID-19 into carbon-, boron-, and aluminum-nitride nanotubes for optimal drug delivery systems combined with molecular docking simulations
por: Albarakati, Roqaya, et al.
Publicado: (2023)

Theoretical investigation of favipiravir antiviral drug based on fullerene and boron nitride nanocages
por: Soliman, Kamal A., et al.
Publicado: (2021)

Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols
por: Bahun, Miha, et al.
Publicado: (2022)

DFT Calculation and MD Simulation Studies on Gemini Surfactant Corrosion Inhibitor in Acetic Acid Media
por: Numin, Mohd Sofi, et al.
Publicado: (2023)

Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
por: Tomar, Sakshi, et al.
Publicado: (2015)

SARS-CoV-2 main protease (3CL(pro)) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking
por: Mohandoss, Sonaimuthu, et al.
Publicado: (2022)

Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PL(PRO) and 3CL(PRO) proteases
por: Jade, Dhananjay, et al.
Publicado: (2021)

Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M(pro) Protease Target Host Selenoproteins and Glutathione Synthesis?
por: Taylor, Ethan Will, et al.
Publicado: (2020)

Synergistic effect of Si-doping and Fe(2)O(3)-encapsulation on drug delivery and sensor applications of γ-graphyne nanotube toward favipiravir as an antiviral for COVID-19: A DFT study
por: Asgari, Mohammad Amin, et al.
Publicado: (2022)

In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
por: Maulana, Saipul, et al.
Publicado: (2023)

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
por: Guedj, Jérémie, et al.
Publicado: (2018)

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021)

Development of Broad‐Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CL(pro)
por: Bacha, Usman, et al.
Publicado: (2008)

The development of Coronavirus 3C-Like protease (3CL(pro)) inhibitors from 2010 to 2020
por: Liu, Yuzhi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q5rgednmocgi23nble4c3810ej